Featured on Industry Leading Website
Skinvisible Pharmaceuticals (OTCQB: SKVI) was featured on CosmeticDesign.com with the announcement of SKVI’s new subsidiary, Kintari. Kintari is a network marketing subsidiary that will complement everything else SKVI does.
Here is the article:
Click on Image Above to View the Article
Skinvisible expands with new anti-aging subsidiary
By Andrew McDougal
Quoting from the article:
“Skinvisible will take further steps into the skin care field after launching a new wholly-owned subsidiary called Kintari that will market a premium line of products powered by the company’s patented Invisicare technology.”
READ THE FULL ARTICLE HERE:
http://www.cosmeticsdesign.com
John Pentony now represents Skinvisible Pharmaceuticals, Inc. as its investor relations coordinator internally. In the past John Pentony’s company was hired for the distribution of news and blogs about Skinvisible. John Pentony and any family member or associated companies do not hold shares, warrants or other positions in Skinvisible stock. In years past John Pentony’s company (Pentony Enterprise LLC / “PE”) has received a total of eight thousand in cash payments. In 2009 PE was compensated 500k shares of restricted stock. John Pentony has signed a contract to as investor relations for Skinvisible, and will be paid up to eleven thousand dollars during the next twelve months should the contract go for twelve months as expected.